AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer patients Read more
Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy Read more
New data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration Read more
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric Oxide nasal spray Read more